List of Contract Manufacturing Companies in Canada - 20

AcuPharma is a Canadian based company that provides a wide range of services for pharmaceutical and biotech partners. Our aim is to assist our clients in reaching their goals by providing chemistry expertise, as well as contract research and custom synthesis.

Affinity Biologicals Inc. is a biotechnology company based in Ancaster, Ontario, Canada, specializing in hemostasis diagnostics and research. Founded in 1987, the company develops, manufactures, and markets over 250 high-quality reagents and kits used in coagulation and thrombosis studies. Their product offerings include coagulation-related antibodies, matched-pair antibody sets for ELISA, depleted/deficient plasmas, and a line of complete ELISA kits. The company also provides tailored services such as research and development, custom manufacturing, and contract services to support clients in the biotechnology and healthcare sectors. Affinity Biologicals maintains a strong commitment to quality, operating under an ISO 13485:2003 registered Quality System and holding licenses from regulatory authorities like the US FDA and Health Canada. With a dedicated team of around 30 employees, Affinity Biologicals serves a global market through a network of distributors.

AtomVie Global Radiopharma Inc. is a contract development and manufacturing organization (CDMO) based in Hamilton, Ontario, Canada. Established in August 2022, the company specializes in the production of radiopharmaceuticals, focusing on both clinical and commercial applications. AtomVie is recognized for its Good Manufacturing Practice (GMP)-compliant production, drawing on over ten years of expertise from its predecessor, the Centre for Probe Development and Commercialization (CPDC). The company is expanding its capabilities with a new multi-product facility, set to significantly increase production capacity. AtomVie offers a range of services, including GMP manufacturing of radiotherapeutics and medical isotopes, regulatory support with a strong approval track record, and logistics management for the global distribution of short-lived radiopharmaceuticals. AtomVie serves over ten international pharmaceutical companies and supports clinical trials across more than 17 countries, emphasizing reliability in its production and logistics processes.

Biolyse Pharma specializes in manufacturing and developingof sterile oncology drugs.- Currently produces Paclitaxel for the treatment of cancer, known for its mild side effects when compared to similar chemotherapy agents- Supplies 80 per cent of the Canadian demand for Paclitaxel

Welcome to Biomatik - Your Quality Source of Integrated Products & Services for Life Sciences and Drug Discovery! ​Biomatik has been proudly serving the life sciences and drug discovery industry since 2002. In the first 10 years, Biomatik had been primarily focusing on Biochemicals, Gene Synthesis, and Peptide Synthesis. In the past 5 years, Biomatik has largely outgrown the above product lines and is rapidly expanding its new product lines: ELISA Kits, Proteins, and Antibodies. Offered Products: 22,000+ ELISA Kits, 26,000+ Antibodies, 15,000+ Proteins, 300+ Biochemicals Offered Services: Gene Synthesis, Peptide Synthesis, Protein Expression and Antibody Production Services To date, in addition to our catalog products, Biomatik has delivered 52,000+ custom-made products to our researchers worldwide. You can count on the quality products and tech support from Biomatik for your research needs. Please​ view our customer testimonials and some of the well-respected publications citing our fine products at Google Scholar​. Biomatik works closely with its partners at the R&D and production levels, along with 35+ distributors all over the world. Our goal is to provide worldwide researchers with high-quality research products and customized solutions at highly competitive prices - to be a truly valuable partner in unveiling the mysteries of the life sciences. We sincerely invite you to join our list of satisfied customers worldwide.

BioNxt Solutions is a leading bioscience company that rapidly innovates drug formulations, diagnostics, drug delivery, and neurological drugs.

Expertise in both microbial fermentation and chemical synthesis allows us to tackle today's development pipeline's increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Synthetic small molecules Fermented small molecules Highly potent APIs Biologics Bioreagents Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We assure the programs advance on time and with the highest quality outcomes under our project managers' leadership.

Be Clinic Ready! Corealis Pharma provides services on a contract basis in the areas of Formulation & Process Development as well as in small scale Clinical Trial Material (Phase I and II) Manufacturing and the packaging of solid dosage forms (tablets & capsules) to pharmaceutical and biotech companies. Our services include: API characterization; salt selection; pre-formulation; formulation & process development; analytical method development; stability storage & testing; technical transfer and scale-up; cGMP manufacturing & packaging of Phase I and II CTM; dossier support for American, European, and Canadian submissions. Our experts have access to modern well equipped R&D and cGMP manufacturing & packaging facilities that allow them to successfully complete the most challenging and complex mandates. The primary objective of Corealis and its staff is to make every one of their customers succeed. Corealis Pharma Inc. offers personalized and efficient services in the areas of Formulation Development and Clinical Supply Manufacturing of solid oral dosage forms.

Dalton is a contract pharmaceutical manufacturer which provides integrated chemistry, development, and manufacturing to biotechnology and pharmaceutical clients around the world. In its 42,000 sq. ft. facility, Dalton operates - cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), - sterile injectables, - finished drug products in vials or syringes - solid oral dosage forms. APIs can be produced in gram to kilogram quantities, including sterile APIs. Dalton contract capabilities can support you at any stage of the regulatory process (Phase I, II, III, or commercial). Development services include - chemistry and process development, - medicinal chemistry, - custom drug conjugation, - targeted drug delivery systems, - analytical method development and validation, - ICH stability testing, - formulation, and - polymorphism screening. Dalton also supports the industry's pharmaceutical research programs with a catalog of 2,500 reference standards, building blocks, metabolites, and impurities with its Dalton Research Molecules division.

At Eyam, our mission is to bring “Next Generation” vaccine and therapeutic technologies to market to solve today's health care needs.

Jubilant HollisterStier Contract Manufacturing & Services is an integrated contract manufacturer of sterile injectables, ophthalmics, otics and sterile topicals and liquids. Our facilities in North America provide specialized manufacturing services for the pharmaceutical and biopharmaceutical industries. We provide a full range of support and services to streamline the manufacturing process such as on-site assistance from process qualifications through product release.

LineaBio's mission is to enable the cell and gene therapy industry by providing access to high-quality, off-the-shelf iPSC lines manufactured under GMP that streamline drug product manufacturing. By allowing therapeutic developers to cut costs and accelerate timelines for GMP reprogramming, LineaBio strives to achieve its vision of making cell therapy universally accessible and affordable. Founded in 2023 by parent companies CCRM and OmniaBio, LineaBio draws on a team of iPSC experts that have been developing an iPSC platform for more than a decade.

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing, and distribution of pharmaceutical products. The company has completed the acquisition of Virage Santé and has entered into an exclusive distribution agreement with Fera Pharmaceuticals to alleviate drug shortage in U.S. hospitals. LSL Pharma Group Inc. is listed on the TSX Venture Exchange under the ticker symbol LSL.V.

Optimi Health exists to grow psychedelic science and medicine as an industry-leading supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds. Our Purpose is to produce scalable, natural mushroom formulations and other psychedelics for transformational human experiences. Our Goal is to be the number one trusted, compassionate supplier of safe, natural EU-GMP-grade psilocybin and synthetic psychedelics across the world. Our Promise is to make possible a future whereby psychedelic alternatives aid a wide variety of mental health conditions.

PharmAla Biotech Inc. is a Canadian Biotechnology company dedicated to the research, development, manufacture and sales of MDMA in service to the clinical research community.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem (located in France) is the recipient of multiple French scientific awards and European Union and French government grants. Sirona Biochem is a publicly-traded company. The company is listed on the TSX Venture Exchange in Canada under the symbol SBM, the OTC Pink Sheets in the United States under the symbol SRBCF and in Frankfurt under the symbol ZSB.

StarFish Medical provides award-winning design, development, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Cardiovascular, Digital Health, IVD, Ophthalmology, Optics, Ultrasound, POC Assay Diagnostic Technologies, and Microfluidics. StarFish expertise includes electronics, mechanical, human factors and software systems engineering. Our proprietary Pathfinder™ process for medical device product definition saves clients time and resources throughout the technology and product development phases to commercialization. Prototype and low volume complex electro-mechanical production are delivered in ISO 13485 certified facilities with cleanroom capabilities in Toronto and Victoria Regulatory and quality system (QMS) consultants at StarFish provide technical regulatory assistance for FDA and Health Canada submissions, including IEC 60601 and ISO13485. Innovative Design and Development  Electronic / software / mechanical engineering  Industrial design / human factors engineering  PathfinderTM product definition process  Technology optimization  Verification / validation / testing  ISO 13485 certified QMS Integrated Manufacturing  Seamless ramp from clinical trials to full production  Deep engineering involvement & oversight  Electro-mechanical / software expertise  Customized cart specialists  Optical instrument build and test  Dedicated program manager Flexible Manufacturing  New product introductions  Supply-chain management  North America facilities  Depot repair & field service  Sustaining / value engineering  Class 100,000 cleanroom

uFluidix specializes in manufacturing silicone (PDMS) and thermoplastic (PMMA, PC, PS, COC, and COP) microfluidic chips and devices for microtechnology applications. Our expertise in the development and processing of these micro-featured components goes beyond the know-how of most of the plastic industry, who use conventional molding, stamping or rolling technologies. Our two differentiators are: 1. We affordably fabricate plastic parts with features accurate within +/- 0.5um if needed. 2. We bond or laminate hard-to-bond parts with less than 1% distortion of their sensitive micro-features. Over 10 years of experience has rewarded uFluidix with knowledge proven to be useful for a wide range of applications. If you are currently conceptualizing, improving, or validating an application from the list below we invite you to a friendly chat with one of our development specialists. We ensure you would hear something from us that is worth the experience. Applications: • Point-of-Care Blood/Urine Analysis Cartridges • Complicated Micro Arrays • Tissue Engineering Scaffolds • Customized Cell Culture Systems • Opto-electrical Methods • Point-of-Care Biomarker Detection • Pathogen Detection in Human/Animal • Optical-MEMS • Toxicity Measurements in Droplet Samples • Drug Efficacy Monitoring in Tiny Body Fluids • Cell Separation • Benchtop Cell Count Measurement • Fluidic Drug Delivery • Cancer Research via Biomarker or Cell Analysis • In-Vitro Platforms for Stem Cell Research • Selective Methods for Fertility Aid • Microfluidic Systems • Point-of-Care Sequencing Solutions • Portable Forensic Devices https://www.ufluidix.com/microfluidics-applications/ Any questions? Please visit ufluidix.com or email us at info@ufluidix.com

Valence Labs is a biotechnology company that specializes in AI-driven drug discovery. It operates as a semi-autonomous research and productization engine within Recursion Pharmaceuticals. The company focuses on leveraging deep learning applications to enhance drug development, particularly for complex diseases. Valence Labs develops software tools that accelerate therapeutic research, including novel target identification and molecular design. In addition to its AI-driven initiatives, Valence Labs is associated with a separate entity that specializes in active pharmaceutical ingredient (API) synthesis. This division offers custom API manufacturing services, including process development and GMP-compliant commercial-scale production. Valence Labs collaborates with biotech partners to provide AI solutions, emphasizing complex chemistry and preclinical optimization.